Regional media highlights UC pancreatic cancer vaccine trial
Regional media highlighted the University of Cincinnati Cancer Center being the first site in the Midwest enrolling patients in a new Phase 2 clinical trial testing a vaccine to treat pancreatic cancer.
Davendra Sohal, MD, site principal investigator, said this trial builds on the same mRNA technology that was used to develop vaccines for COVID-19.
"In addition to the standard surgery and chemotherapy, they also get this very personalized vaccine created using their own tumor profile,” Sohal, associate director for clinical research at the Cancer Center and professor of internal medicine in UC’s College of Medicine, told Local 12.
The vaccine is developed in about four to six weeks while patients are recovering from surgery, and patients are then given six weekly injections of the vaccine. Following six months of standard chemotherapy, patients then receive six more vaccine injections as boosters.
In the Phase 1 trial, Sohal said eight out of 32 patients were completely cured of their cancer.
Watch or read the Local 12 story.
Read the Becker's Hospital Review story.
Read the WDRB Louisville story.
For more information on the trial, please call 513-584-7698 or email cancer@uchealth.com.
Featured photo at top of a vaccine being administered. Photo/National Cancer Institute/Unsplash.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
UC Board votes to fund design for YMCA renovation
October 28, 2025
At its October 28, 2025 meeting, the University of Cincinnati Board of Trustees approved $5 million in funding to complete all design and pre-construction services required to renovate the interior of a former YMCA building located at 270 Calhoun Street.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.